Biobanks play a crucial role in the discovery of disease-specific biomarkers, drug discovery, and clinical and translational research. Large biobanks perform several activities such as sample acquisition, collection, sample preparation, storage, testing, analysis, distribution, etc. These activities have an impact on sample quality. Biobanks must maintain the quality of samples so that they are useful for research. Biobanks are also responsible for ensuring patient privacy. Hence, biobanks must safeguard Protected Health Information (PHI), manage patient consent, and ensure that biospecimens collected from patients are used for intended purposes only, for example, cohort studies, etc. Biobanks face numerous challenges, including managing biospecimens, associated metadata, and patient consent, locating stored samples, standardizing operational workflows, ensuring sample integrity, preventing unauthorized access to sensitive data, and following regulatory guidelines such as ISO 20387, HIPAA, EU GDPR, 21 CFR Part 11, audit trail, etc. CloudLIMS helps in securely managing sample and patient data, assigning role-based access to authorized users, following regulatory guidelines, removing data silos, and generating personalized reports. Being hosted in the cloud, CloudLIMS helps in minimizing operational costs for biorepositories and in ensuring data integrity and security.